Abstract

A complex interaction of anabolic and catabolic metabolism underpins the ability of leukocytes to mount an immune response. Their capacity to respond to changing environments by metabolic reprogramming is crucial to effector function. However, current methods lack the ability to interrogate this network of metabolic pathways at single-cell level within a heterogeneous population. We present Met-Flow, a flow cytometry-based method capturing the metabolic state of immune cells by targeting key proteins and rate-limiting enzymes across multiple pathways. We demonstrate the ability to simultaneously measure divergent metabolic profiles and dynamic remodeling in human peripheral blood mononuclear cells. Using Met-Flow, we discovered that glucose restriction and metabolic remodeling drive the expansion of an inflammatory central memory T cell subset. This method captures the complex metabolic state of any cell as it relates to phenotype and function, leading to a greater understanding of the role of metabolic heterogeneity in immune responses.

Patricia Ahl et al. present Met-Flow, a flow cytometry-based approach for capturing the metabolic state of immune cells across multiple pathways. The authors apply Met-Flow to a central memory T cell subset, showing the importance of glucose restriction and metabolic reprogramming to T cell polarization and expansion.

Details

Title
Met-Flow, a strategy for single-cell metabolic analysis highlights dynamic changes in immune subpopulations
Author
Ahl, Patricia J 1   VIAFID ORCID Logo  ; Hopkins, Richard A 2 ; Xiang Wen Wei 2 ; Au Bijin 3 ; Nivashini, Kaliaperumal 3 ; Fairhurst Anna-Marie 3 ; Connolly, John E 4 

 Agency for Science, Technology and Research, Institute of Molecular and Cell Biology, Singapore, Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221); National University of Singapore, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431) 
 Agency for Science, Technology and Research, Institute of Molecular and Cell Biology, Singapore, Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221); Agency for Science, Technology and Research, Tessa Therapeutics Pte Ltd, Institute of Molecular and Cell Biology, Singapore, Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221) 
 Agency for Science, Technology and Research, Institute of Molecular and Cell Biology, Singapore, Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221) 
 Agency for Science, Technology and Research, Institute of Molecular and Cell Biology, Singapore, Singapore (GRID:grid.185448.4) (ISNI:0000 0004 0637 0221); National University of Singapore, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Baylor University, Institute of Biomedical Studies, Waco, USA (GRID:grid.252890.4) (ISNI:0000 0001 2111 2894) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2412413440
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.